Evidence map›Paper›PMID 37069571›Full record

ArticleBMC infectious diseases2023

Bidirectional screening and testing for TB and COVID-19 among outpatient department attendees: outcome of an initial intervention in Ghana.

Yaw Adusi-Poku, Zeleke Alebachew Wagaw, Rita Patricia Frimpong-Mansoh, Isaac Opoku Asamoah, Felix Sorvor, Felix Kwami Afutu, Charity Sarpong, Luiz Octaviano Amoussou-Gohoungo, Farida Ngelba Abdulai, Sevim Ahmedov

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Yaw Adusi-PokuNational Tuberculosis Programme, Ghana Health Service, Accra, Ghana.
Zeleke Alebachew WagawNational Tuberculosis Programme, Ghana Health Service, Accra, Ghana. zalebachew@gmail.com.
Rita Patricia Frimpong-MansohNational Tuberculosis Programme, Ghana Health Service, Accra, Ghana.
Isaac Opoku AsamoahRegional Health Directorate Greater Accra, Ghana Health Service, Accra, Ghana.
Felix SorvorNational Tuberculosis Programme, Ghana Health Service, Accra, Ghana.
Felix Kwami AfutuNational Tuberculosis Programme, Ghana Health Service, Accra, Ghana.
Charity SarpongRegional Health Directorate Greater Accra, Ghana Health Service, Accra, Ghana.
Luiz Octaviano Amoussou-GohoungoRegional Health Directorate Greater Accra, Ghana Health Service, Accra, Ghana.
Farida Ngelba AbdulaiRegional Health Directorate Greater Accra, Ghana Health Service, Accra, Ghana.
Sevim AhmedovUnited States Agency for International Development (USAID), Bureau for Global Health, Washington, USA.
Ghana Health Service · GHUnited States Agency for International Development · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis (TB) remains a major public health threat in Ghana. The impact of COVID-19 resulted in a 15% decline of TB case notification in 2020 compared to 2019. To mitigate the impact on TB services, the Ghana National Tuberculosis Programme (NTP) introduced the bidirectional screening and testing for TB and COVID-19 in 2021.

objectiveTo evaluate the yield of bidirectional screening and testing for TB and COVID-19 among facility attendees in the Greater Accra region.

methodWe used secondary data obtained from the initial implementation stage of the bidirectional testing for TB and COVID-19 among COVID-19 and/or TB presumed cases in five health facilities in the Greater Accra Region from January to March 2021. To mitigate the impact of COVID-19 on TB services and accelerate TB case detection, the NTP of Ghana introduced bidirectional screening and testing for TB and COVID-19 in Greater Accra Region before scaling up at national level.

resultsA total of 208 presumed TB or COVID-19 cases were identified: 113 were tested for COVID-19 only, and 94 were tested for both TB and COVID-19, 1 was tested for TB only. Among presumed cases tested for COVID-19, 9.7% (95% CI, 5.6-13.7%) were tested positive. Whilst among the total presumed tested for TB, 13.7% (95% CI, 6.8-20.6%) were confirmed to have TB. Among the total 94 presumed cases tested for both TB and COVID-19, 11.7% (95% CI, 5.2-18.2%) were confirmed to have TB and 13.8% (95% CI, 6.9-20.8%) participants were COVID-19 positive and one participant (1.1%) had both COVID-19 and TB.

conclusionBidirectional screening and testing for TB and COVID-19 shows significant potential for improving overall case detection for the two diseases. The bidirectional screening and testing could be applicable to address a similar respiratory epidemic in the future that might have a masking effect on the response to TB disease.

Indexed as

COVID-19TuberculosisGhanaHealth FacilitiesHumansOutpatientsGhanaScreening of facility attendeesSimultaneous testing of COVID-19 and TBTB case detectionYield of TB and COVID-19 screening

Identifiers

PMID37069571
PMCPMC10107550
OpenAlexW4366189527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.